Drug Shortage Report for IPRAVENT
| Report ID | 2199 |
| Drug Identification Number | 02246083 |
| Brand name | IPRAVENT |
| Common or Proper name | IPRAVENT |
| Company Name | AA PHARMA INC |
| Market Status | DORMANT |
| Active Ingredient(s) | IPRATROPIUM BROMIDE |
| Strength(s) | 0.03% |
| Dosage form(s) | SOLUTION |
| Route of administration | NASAL |
| Packaging size | 15 ML |
| ATC code | R01AX |
| ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2015-04-15 |
| Estimated end date | Unknown |
| Actual end date | 2017-07-28 |
| Shortage status | Resolved |
| Updated date | 2020-08-06 |
| Company comments | product discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-03-14 | English | Compare |
| v2 | 2017-03-14 | French | Compare |
| v3 | 2020-08-06 | English | Compare |
| v4 | 2020-08-06 | French | Compare |
Showing 1 to 4 of 4